Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Jane Fonda Announces Non-Hodgkin Lymphoma Diagnosis

September 3rd 2022

Actress Jane Fonda announced that she has been diagnosed with non-Hodgkin lymphoma and will be receiving chemotherapy to treat the blood cancer.

Revlimid-Rituxan Combo May Offer Alternative to Chemotherapy for Lymphoma Subtype

August 22nd 2022

The combination treatment demonstrated survival and safety results similar to those of chemotherapy for patients with advanced, untreated follicular lymphoma.

FDA Lifts Partial Hold on Trial Investigating Emavusertib in Lymphoma

August 19th 2022

The FDA has allowed the manufacturer of emavusertib to continue a phase 1/2 study investigating effects of the treatment in patients with lymphoma.

ESPN Analyst Dick Vitale Announces He is Cancer-Free, WHO Deems Firefighting a Cancer-Causing Profession and More

August 19th 2022

From ESPN analyst Dick Vitale announcing he is cancer-free months following a lymphoma diagnosis to a Speedo-clad race in South Africa to raise awareness for cancer, here’s what’s happening in the oncology space this week.

First Patient Receives Treatment With Investigational CAR-T Cell Therapy-Opdivo Combo for Hodgkin Lymphoma

August 18th 2022

A representative of the company developing the investigational CAR-T cell therapy noted that they hypothesize that the combination “has the potential to further enhance efficacy and provide patients with a chemotherapy-sparing, second-line treatment option.”

FDA Approves Tablet Version of Calquence to Treat Multiple Blood Cancers

August 5th 2022

The tablet version of Calquence, which was approved by the FDA for the treatment of chronic lymphocytic leukemia, small lymphocytic leukemia and relapsed/refractory mantle cell lymphoma, may be taken alongside other drugs to reduce gastric-related side effects.

Does My Cancer Give Me a Pass at Patience?

August 4th 2022

When my grandmother passed, I noticed my aunt was ruder than usual, and I wondered if I was like that during my cancer experience... and if the pain I was going through excused that behavior.

Dick Vitale Receives Jimmy V Award, Cancer Survivor Will Use Golf Scholarship to Study Medicine and More

July 22nd 2022

From Dick Vitale receiving the Jimmy V Award at the 2022 ESPYs to a former triathlon champion opening up about his cancer experience, here’s what’s happening in the cancer space this week.

FDA to Speed Up Review of Novel CAR-T Cell Therapy for Rare Forms of Lymphoma and Leukemia

July 19th 2022

A first-in-human trial is investigating the safety and efficacy of the novel CAR-T cell therapy in patients relapsed or refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

Early-Phase Trial Assessing Novel CAR-T Cell Therapy in a Type of Blood Cancer Terminated

July 12th 2022

The manufacturer of the novel CAR-T cell therapy announced it terminated an early-phase trial investigating the treatment’s efficacy after there was a lack of benefit in patients with relapsed or refractory T-cell lymphoma, a type of blood cancer.

FDA’s Approval of Breyanzi Gives Some Patients With Lymphoma a ‘Life-Saving Therapy', Says Expert

July 8th 2022

The FDA approval of Breyanzi, a novel CAR-T cell therapy, provides many patients with lymphoma a new treatment option that can be used earlier in the course of their disease, according to an expert.

FDA Approves Breyanzi for Previously Treated Large B-Cell Lymphoma

June 27th 2022

The FDA approval of Breyanzi, a CAR-T cell therapy, offers patients with relapsed/refractory lymphoma the opportunity for long-term remission, and hope for a cure, one expert said.

Robin Roberts Provides an Update on Her Partner’s Cancer, Supreme Court Rejects Bayer’s Roundup Appeals and More

June 24th 2022

From Robin Roberts’ personal message about her partner, Amber Laign’s cancer, to a dancing group inspired by an “America’s Got Talent” contestant who died of cancer, here’s what is happening in the cancer space this week.

FDA Approves Kymriah for Relapsed/Refractory Follicular Lymphoma

May 31st 2022

Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.

Chemotherapy Hair Hacks: From Lint Rollers to Duct Tape

May 24th 2022

Losing my hair due to cancer treatment was mentally and physically painful, but I learned a few tips and tricks along the way.

My Experiences With My Cancer Support Systems Were Unfortunate

May 19th 2022

When you put your feelings out there in cancer support groups — be it in-person or virtual — you’re opening your ideas up to others’ interpretation, and some might not like what you have to say.

I Was Preparing to Be an Oncology Nurse, That is Until My Sister's Cancer Returned

May 17th 2022

Watching my sister undergo cancer treatment made me want to become a nurse, though after she was re-diagnosed, I’ve had to step away from that career path.

Stop Saying Cancer is a 'Battle'

May 10th 2022

I can’t stand the “battle language” of cancer, including terms like “cancer warrior” and “losing the battle” with the disease.

‘Leave It to Beaver’ Star Announces Cancer Diagnosis, Woman Receives Prison Sentence for Faking Cancer Treatment to Collect Donations and More

May 6th 2022

From “Leave It to Beaver” actor Tony Dow revealing his cancer diagnosis to a woman faking a cancer diagnosis to collect $100,000 in donations and a European soccer star finishing treatment, here’s what’s happening in the cancer space this week.

My Sister's Cancer Journey Has Taught Me to Live Moment by Moment

May 5th 2022

After my sister was re-diagnosed with stage 4 cancer, I was reminded to find laughter in every day because nobody knows what tomorrow holds.

Long-Term Axi-Cel Data ‘May Be Suggestive of a Cure’ in Patients With Large B-Cell Lymphoma

April 26th 2022

The majority of patients with relapsed/refractory large B-cell lymphoma were alive between four and five years after being treated with axi-cel.

Better Data Needed to Approve Future PI3K Inhibitors for Blood Cancers, FDA Panel Recommends

April 25th 2022

A panel of experts on the FDA’s Oncologic Drugs Advisory Committee voted that all future approvals of PI3K inhibitors to treat blood cancer be backed by randomized clinical trial data.

Novel Drug Elicits High Response Rates in Relapsed/Refractory Lymphoma Subset

April 20th 2022

Findings from an early-phase clinical trial show that treatment with epcoritamab led to a 63.1% response rate in patients with pretreated large B-cell lymphoma.

Patients With Cancer Don't Owe 'Grief Tourists' Anything

April 19th 2022

After going public with my cancer diagnosis, I was met with an onslaught of “grief tourists” who may not have been interested in the harsh realities of cancer.

Has Cancer Survivorship Made Me Weak?

April 13th 2022

After surviving cancer, I’ve developed complex post-traumatic stress disorder, which comes with feelings of insecurity and anger.

First Patient With Lymphoma Receives Novel Cell Therapy in Large-Scale Trial

April 5th 2022

The plan is to assess the safety and efficacy of the genetically engineered cell therapy alongside high-dose chemotherapy and blood stem cell transplantation in approximately 150 patients with lymphoma.

FDA Approves Yescarta, First CAR-T Cell Therapy, for Patients With Large B-Cell Lymphoma That Has Failed Initial Treatment

April 4th 2022

The FDA’s decision to approve Yescarta in patients with large B-cell lymphoma that has failed to respond to first-line treatment is based on data that showed that the use of the CAR-T cell therapy resulted in a significant increase in patients who were alive at two years compared with the standard-of-care second-line treatment.

‘I Would Have Given Up a Long Time Ago’ and Other Things Not to Say to Cancer Survivors

March 23rd 2022

My survivor friends and I share the insensitive comments we have received about our cancer diagnosis.

CAR-T Cell Therapies Offer ‘An Opportunity for Majority of Patients’ With Lymphoma to Be Treated

March 14th 2022

Unlike stem cell transplant, which has strict eligibility criteria, the majority of patients with blood cancer may be able to receive CAR-T cell therapy, regardless of other comorbidities, explained an expert.

Cancer Changed My Relationship With Pain: ‘Being a Trooper’ Is Not Always a Good Thing

March 10th 2022

After seeing my brother go through extraordinary pain because of lymphoma and then surviving breast cancer myself, I always pushed through the pain — even when I shouldn’t have.

NEXT PAGE
PREVIOUS PAGE